Novel etiological agent: molecular evidence for trematode-induced anterior uveitis in children.

(Dr Hatch), Medicine (Dr Bell), and Health Policy, Management, and Evaluation (Dr Bell), University of Toronto, Toronto, Department of Ophthalmology, Queen’s University and Hotel Dieu Hospital, Kingston (Drs E. de L. Campbell, El-Defrawy, and R. J. Campbell), and Institute for Clinical Evaluative Sciences, Kingston and Toronto (Drs Bell and R. J. Campbell), Ontario, Canada. Correspondence: Dr R. J. Campbell, Department of Ophthalmology, Queen’s University, Hotel Dieu Hospital, 166 Brock St, Kingston, Ontario, Canada K7L 5G2 (rob [email protected]). Author Contributions: Drs Hatch and R. J. Campbell had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Conflict of Interest Disclosures: None reported. Funding/Support: Dr Bell is supported by a Canadian Institutes of Health Research and Canadian Patient Safety Institute chair in Patient Safety and Continuity of Care. Dr R. J. Campbell is supported by a Clinician Scientist Award from the Southeastern Ontario Academic Medical Organization and Queen’s University. Drs Bell and R. J. Campbell are affiliated with the Institute for Clinical Evaluative Sciences, which is funded by an annual grant from the Ontario Ministry of Health and Longterm Care. Role of the Sponsors: The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript. Disclaimer: The opinions, results, and conclusions reported in this article are those of the authors and are independent from the sponsors. No endorsement by the Institute for Clinical Evaluative Sciences or the Ontario Ministry of Health and Long-term Care is intended or should be inferred.